1.888.666.2560

clinical data to control bleeding

Syvek® Ensures Effective Control of Bleeding

Syvek has been used on more than 3 million patients*. The product's efficacy is supported by documented case studies and peer-reviewed literature.



Indications for Use:
SyvekNT® is intended for the promotion of rapid control of bleeding in patients following hemodialysis and in patients on anticoagulation therapy. SyvekNT is intended for use in the local management of bleeding wounds such as vascular access site, percutaneous catheters or tubes and surgical debridement. Syvek Excel® is intended for use following femoral vascular catheterization procedures to assist in obtaining and maintaining hemostasis.

Safety Information:
PRECAUTIONS: There are no known contraindications to the use of SyvekNT®. Longer compression may be necessary for hypertensive or obese patients. There are no known contraindications to the use of Syvek Excel®. Longer compression may be necessary for hypertensive or obese patients.
Not made with Natural Rubber Latex
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner.

Manufactured by Marine Polymer Technologies, Inc., Danvers, MA 01923. For instructions for use or additional product information, please contact us.

  • 8,992,453
  • 8,859,528
  • 8,835,408
  • 8,834,516
  • 8,481,512
  • 8,152,750
  • 7,931,637
  • 7,115,588
  • 7,041,657

* Data on file, based on total US sales

** Angiomax®(bivalirudin) is a registered trademark of The Medicines Company